The capital has 28,620 doses of Covaxin and 5,20,860 doses of Covishield in stock for those aged above 45, frontline workers and healthcare workers, AAP leader Atishi said.
The government of India has been supporting the efforts of states and UTs for an effective vaccination drive under the Whole of Government approach since January 16 this year.
In a bizarre move, centre asks states not to share data on vaccine stocks [details]
Amidst sharp criticism of its Wednesday order, the center today issued a clarification in which it argued that the order was issued to prevent commercial abuse of the data by other entities.
Covid treatment guidelines for children
The Union Health Ministry on Wednesday issued a letter to all the states, directing against sharing eVIN data on vaccine supplies. The order, which was issued to all states and UTs, stated that the ministry owns data on vaccine stockpiles and temperature at all levels of vaccine storage and that it should not be shared without its permission. Soon after the order was issued many public activists termed it a gag order.
Centre asks states not to share data on vaccine stocks, temperature of vaccine storage in public
SECTIONS
Centre asks states not to share data on vaccine stocks, temperature of vaccine storage in publicPTI
Last Updated: Jun 09, 2021, 08:54 PM IST
Share
Synopsis
The Centre has written to the states and Union territories, advising them not to share the data of the Electronic Vaccine Intelligence Network (eVIN) system on vaccine stocks and the temperature of vaccine storage at public forums, and stating that it is a sensitive information and to be used only for programme improvement .
Representative image
The Centre has written to the states and Union territories, advising them not to share the data of the Electronic Vaccine Intelligence Network (eVIN) system on vaccine stocks and the temperature of vaccine storage at public forums, and stating that it is a sensitive information and to be used only for programme improvement .
The move comes at a time when questions are being raised on the lack of centralised vaccine availability data in public domain and opacity in the vaccine distribution plan to states.